{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:41:12Z","timestamp":1787244072887,"version":"build-2736575974"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00415-025-13106-z","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T12:02:59Z","timestamp":1745928179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Utility of spinal cord axial-T2 sequence in a population-based cohort of multiple sclerosis"],"prefix":"10.1007","volume":"272","author":[{"given":"Laura","family":"Cacciaguerra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Madhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl N.","family":"Krecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Oliver","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Mendelt","family":"Tillema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Zeydan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Assunta","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhun H.","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-2910","authenticated-orcid":false,"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"13106_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"13106_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000435","volume":"5","author":"B Zeydan","year":"2018","unstructured":"Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH (2018) Cervical spinal cord atrophy: an early marker of progressive MS onset. Neurol Neuroimmunol Neuroinflamm 5:e435","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13106_CR3","doi-asserted-by":"publisher","first-page":"e628","DOI":"10.1212\/WNL.0000000000007944","volume":"93","author":"E Sechi","year":"2019","unstructured":"Sechi E, Keegan BM, Kaufmann TJ, Kantarci OH, Weinshenker BG, Flanagan EP (2019) Unilateral motor progression in MS: association with a critical corticospinal tract lesion. Neurology 93:e628\u2013e634","journal-title":"Neurology"},{"key":"13106_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","volume":"20","author":"MP Wattjes","year":"2021","unstructured":"Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, Fazekas F, Filippi M, Frederiksen J, Gasperini C, Hacohen Y, Kappos L, Li DKB, Mankad K, Montalban X, Newsome SD, Oh J, Palace J, Rocca MA, Sastre-Garriga J, Tintore M, Traboulsee A, Vrenken H, Yousry T, Barkhof F, Rovira A, Magnetic Resonance Imaging in Multiple Sclerosis study g, Consortium of Multiple Sclerosis C, North American Imaging in Multiple Sclerosis Cooperative MRIgwg (2021) 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol 20:653\u2013670","journal-title":"Lancet Neurol"},{"key":"13106_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00415-016-8353-3","volume":"264","author":"MO Breckwoldt","year":"2017","unstructured":"Breckwoldt MO, Gradl J, Hahnel S, Hielscher T, Wildemann B, Diem R, Platten M, Wick W, Heiland S, Bendszus M (2017) Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patients. J Neurol 264:341\u2013349","journal-title":"J Neurol"},{"key":"13106_CR6","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3174\/ajnr.A4638","volume":"37","author":"S Galler","year":"2016","unstructured":"Galler S, Stellmann JP, Young KL, Kutzner D, Heesen C, Fiehler J, Siemonsen S (2016) Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis. AJNR Am J Neuroradiol 37:963\u2013969","journal-title":"AJNR Am J Neuroradiol"},{"key":"13106_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s003300050998","volume":"10","author":"JC Bot","year":"2000","unstructured":"Bot JC, Barkhof F, Lycklama a Nijeholt GJ, Bergers E, Polman CH, Ader HJ, Castelijns JA, (2000) Comparison of a conventional cardiac-triggered dual spin-echo and a fast STIR sequence in detection of spinal cord lesions in multiple sclerosis. Eur Radiol 10:753\u2013758","journal-title":"Eur Radiol"},{"key":"13106_CR8","first-page":"1555","volume":"17","author":"K Hittmair","year":"1996","unstructured":"Hittmair K, Mallek R, Prayer D, Schindler EG, Kollegger H (1996) Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. AJNR Am J Neuroradiol 17:1555\u20131565","journal-title":"AJNR Am J Neuroradiol"},{"key":"13106_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00234-012-1118-5","volume":"55","author":"A Ozturk","year":"2013","unstructured":"Ozturk A, Aygun N, Smith SA, Caffo B, Calabresi PA, Reich DS (2013) Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T. Neuroradiology 55:431\u2013439","journal-title":"Neuroradiology"},{"key":"13106_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/1352458512442754","volume":"18","author":"K Weier","year":"2012","unstructured":"Weier K, Mazraeh J, Naegelin Y, Thoeni A, Hirsch JG, Fabbro T, Bruni N, Duyar H, Bendfeldt K, Radue EW, Kappos L, Gass A (2012) Biplanar MRI for the assessment of the spinal cord in multiple sclerosis. Mult Scler 18:1560\u20131569","journal-title":"Mult Scler"},{"key":"13106_CR11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1474-4422(23)00148-5","volume":"22","author":"AJ Solomon","year":"2023","unstructured":"Solomon AJ, Arrambide G, Brownlee WJ, Flanagan EP, Amato MP, Amezcua L, Banwell BL, Barkhof F, Corboy JR, Correale J, Fujihara K, Graves J, Harnegie MP, Hemmer B, Lechner-Scott J, Marrie RA, Newsome SD, Rocca MA, Royal W 3rd, Waubant EL, Yamout B, Cohen JA (2023) Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol 22:750\u2013768","journal-title":"Lancet Neurol"},{"key":"13106_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.993645","volume":"13","author":"L Cacciaguerra","year":"2022","unstructured":"Cacciaguerra L, Sechi E, Rocca MA, Filippi M, Pittock SJ, Flanagan EP (2022) Neuroimaging features in inflammatory myelopathies: a review. Front Neurol 13:993645","journal-title":"Front Neurol"},{"key":"13106_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, Chitnis T, Brandt AU, Hemingway C, Neuteboom R, Pandit L, Reindl M, Saiz A, Sato DK, Rostasy K, Paul F, Pittock SJ, Fujihara K, Palace J (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria. Lancet Neurol 22:268\u2013282","journal-title":"Lancet Neurol"},{"key":"13106_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"13106_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163","journal-title":"J Chiropr Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13106-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13106-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13106-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:41:43Z","timestamp":1747644103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13106-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["13106"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13106-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Laura Cacciaguerra received speaker and consultant honoraria from ACCMED, Roche, BMS Celgene, and Sanofi and travel support for conferences from Merck Serono. She serves as Review Editor for Brain Health and Clinical Neuroscience (section of Frontiers in Human Neuroscience) and Clinical Neuroimaging (section of Frontiers in Neuroimaging). Ajay Madhavan reports no disclosures. Elia Sechi received speaker honoraria and\/or support for attending scientific meetings from Alexion, Horizon, Novartis, Roche, and UCB. He serves as an editorial board member for BMC Neurology and Frontiers in Neurology. Dr. Sechi is a member of the medical advisory board of the MOG project. Karl N. Krecke reports no disclosures. Sean J. Pittock has received personal compensation for serving as a consultant for Roche\/Genentech, Sage Therapeutics, Arialys, and Astellas. He has received personal compensation for serving on scientific advisory boards or data safety monitoring boards for F. Hoffman-La Roche AG, Genentech, Arialys, and UCB. His institution has received compensation for serving as a consultant for Astellas, Alexion, and Viela Bio\/MedImmune. All compensation is paid to Mayo Clinic. He has received research support from Alexion, Viela Bio\/MedImmune, Roche\/Genentech, and Adimmune. He has a patent, Patent# 8,889,102 (Application#12\u2013678350, Neuromyelitis Optica Autoantibodies as a Marker for Neoplasia)\u2014issued, and a patent, Patent# 9,891,219B2 (Application#12\u2013573942, Methods for Treating Neuromyelitis Optica (NMO) by Administration of Eculizumab to an individual that is Aquaporin-4 (AQP4)-IgG Autoantibody positive)\u2013\u2013issued, and from which he has received royalties and a patent for GFAP-IgG, Septin-5-IgG, MAP1B-IgG, Kelch-like protein 11, and PDE10A pending. He is working as a consultant in the Mayo Clinic Neuroimmunology laboratory clinical service. The Mayo Clinic Neuroimmunology Laboratory commercially offers MOG-IgG testing, but revenue accrued does not contribute to salary, research support, or personal income. Brian G. Weinshenker receives payments for serving as chair of attack adjudication committees for clinical trials in neuromyelitis optica spectrum disorder for Alexion, MedImmune, UCB Bioscience, and Viela Bio\/Horizon Therapeutics; has consulted with CANbridge Pharmaceuticals, Chugai, Genentech, Horizon Therapeutics, Mitsubishi Tanabe Pharma, and Roche Pharmaceuticals; has received payments for speaking for Genentech, Horizon Therapeutics, and Roche; and has a patent for NMO-IgG for diagnosis of neuromyelitis optica, with royalties paid by Hospices Civils de Lyon, MVZ Labor PD Dr. Volkmann und Kollegen GbR, RSR Limited, and the University of Oxford. W. Oliver Tobin has received grants from the National Institutes of Health, and book royalties from the publication of Mayo Clinic Cases in Neuroimmunology (Mayo Clinic Scientific Press) 2022. B. Mark Keegan served as a consultant to EMD Serono, is a member of the Center for Multiple Sclerosis and Autoimmune Research Mayo Clinic, receives publishing royalties for Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases, and is an Editorial Board member of Multiple Sclerosis and Related Disorders. Jan-Mendelt Tillema is an Associate Editor for Journal of Child Neurology. Burcu Zeydan reports funding from the NIH (NIA: U54 AG44170) and is supported by the Mayo Clinic Eugene and Marcia Applebaum Award.John J. Chen reports payment for consultation from UCB and Horizon. Massimo Filippi is the Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, and Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, and Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol Myers Squibb, Lilly, Novartis, and Sanofi-Genzyme; and receives research support from Biogen Idec, Merck Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. Maria Assunta Rocca received consulting fees from Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, and Roche; and speaker honoraria from AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi, and Teva. She receives research support from the MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. She is an Associate Editor for Multiple Sclerosis and Related Disorders. Orhun H. Kantarci reports no disclosures. Eoin P. Flanagan has served on advisory boards for Alexion, Genentech, and Horizon Therapeutics. He has received speaker honoraria from Pharmacy Times. He received royalties from UpToDate. Dr. Flanagan was a site primary investigator in a randomized clinical trial on Inebilizumab in neuromyelitis optica spectrum disorder run by MedImmune\/Viela Bio\/Horizon Therapeutics. Dr. Flanagan has received funding from the NIH (R01NS113828). Dr. Flanagan is a member of the medical advisory board of the MOG project. Dr. Flanagan is an editorial board member of the Journal of the Neurological Sciences and Neuroimmunology Reports. A patent has been submitted on DACH1-IgG as a biomarker of paraneoplastic autoimmunity.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Mayo Clinic and Olmsted Medical Center institutional review boards. Patients or their guardians consented to the use of their medical records for research purposes. This study conforms to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"367"}}